Monthly Archives: February 2017

All Strikes for Young Professionals at Sacco’s Bowl Haven

By | February 22, 2017

The Young Professionals bowling event at Sacco’s Bowl Haven (Flatbread’s Pizza) in Somerville was a big hit for the fourth year in a row. An enthusiastic group of 28 young professionals and students turned out for a night of candlepin bowling, delicious pizza and an opportunity to make new connections. The YPs represented a wide… Read More »

Massachusetts Joins Institute for Innovation in Biopharm Manufacturing

By | February 21, 2017

Massachusetts will be a partner in the nation’s first manufacturing innovation institute in biopharmaceutical manufacturing. The $250 million biopharmaceutical innovation institute is a national, public-private partnership, with federal matching funds provided by the US Department of Commerce’s National Institute of Standards and Technology. Massachusetts will anchor the northeastern node for the institute, which will be… Read More »

Broad Institute CRISPR Patents Upheld

By | February 16, 2017

Broad Institute has announced that the patents granted to MIT, Harvard and Broad Institute concerning CRISPR editing of eukaryotic genomes do not interfere with patent claims filed by UC Berkeley and the University of Vienna, according to a decision handed down by the U.S. Patent Trial and Appeal Board on February 15. The decision confirms… Read More »

Devens’ BMS Integrates New Capabilities in an Existing Plant & Wins ISPE Facility Integration Award

By | February 16, 2017

The Bristol-Myers Squibb (BMS) campus at Devens is part of the company’s Global Manufacturing Network. The two newest facilities, the Biologics Development Building (BDB) and the Clinical Manufacturing Building (CMB), recently earned BMS the ISPE Facility of the Year (FOYA) Facility Integration Award. The new facilities were designed and built in an efficient manner and… Read More »

Amgen’s Humira Biosimilar Moves Forward in Europe Amid Patent Fight with Abbvie

By | February 6, 2017

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing of ABP 501, a biosimilar for Abbvie’s Humira (adalimumab). The committee recommended approval for all available indications, including moderate-to-severe rheumatoid arthritis, chronic plaque psoriasis, Crohn’s disease and ulcerative colitis. ABP 501 is the first Humira… Read More »

Takeda to Acquire ARIAD Pharmaceuticals

By | February 5, 2017

Takeda Pharmaceuticals has announced it will acquire all of the outstanding shares in ARIAD for $24.00 per share in cash, for a total value of approximately $5.2 billion. The transaction is expected to close by the end of February 2017. The acquisition of Cambridge-based ARIAD adds new investigational oncology products to Takeda’s pipeline, including Brigatinib… Read More »

Student Career Workshop: “Best Session I’ve Ever Attended!”

By | February 3, 2017

Comments ranged from “spectacular” to “best session I’ve ever attended” as the Chapter’s Annual Student Career Workshop wrapped up on Saturday, January 28 at Northeastern’s Raytheon Amphitheater. The full-day event was extremely well attended, making this – our fifth Career Workshop – the biggest to date.  Attendees gained valuable guidance, advice, and tips from 15… Read More »

Pharmaceutical Water and Steam: Important Updates on the State-of-the-Art

By | February 3, 2017

The pharma and biotech industries spend millions of dollars annually in costly investigations into alert, action, and out of specification excursions related to the critical utilities of water and steam. These expenditures could be greatly minimized if the issues and challenges related to sampling were clearly understood. To address this knowledge gap, ISPE has introduced… Read More »